Showing 5491-5500 of 5643 results for "".
- Oculus Announces Release of Smartfield Smart Compact Perimeterhttps://modernod.com/news/oculus-announces-release-of-smartfield-smart-compact-perimeter/2479897/Oculus has announced the release of its Smartfield perimeter, expanding its portfolio of compact visual field testing devices. The new Smartfield has been optimized specifically for examinations for functional impairment of the central visual field, but is also suited for peripheral measurements.
- Apellis Announces First Patient Dosed in Its Phase 3 Clinical Program for APL-2 in Patients With Geographic Atrophyhttps://modernod.com/news/apellis-announces-first-patient-dosed-in-its-phase-3-clinical-program-for-apl-2-in-patients-with-geographic-atrophy/2479898/Apellis Pharmaceuticals announced that it has commenced its phase 3 clinical program for APL-2 in patients with geographic atrophy (GA), consisting of two phase 3 trials (DERBY & OAKS.) The first patient has been dosed in the OAKS trial and the first patient has been enrolled in the
- Orbis and Visulytix Unveil Collaboration to Integrate AI Into Global Eye Health Effortshttps://modernod.com/news/orbis-and-visulytix-unveil-collaboration-to-integrate-ai-into-global-eye-health-efforts/2479903/Eye doctors in low-resource countries will receive sophisticated diagnostic technology thanks to a new collaboration between Orbis International, a nonprofit organization fighting global blindnes
- Gaming for an Independent Life: Hope for Visually Impaired Children with New Computer Gamehttps://modernod.com/news/gaming-for-an-independent-life-hope-for-visually-impaired-children-with-new-computer-game/2479909/A new computer game, which developers say could help visually-impaired children lead independent lives, has been rolled out online and it is being made freely available for families, schools, and healthcare providers. The browser-based game, called Ey
- Contact Lens Companies Seek Summary Judgment in Lawsuit Over Minimum Pricinghttps://modernod.com/news/contact-lens-companies-seek-summary-judgment-in-lawsuit-over-minimum-pricing/2479910/Three contact lens companies and a distributor, who are defendants in a class-action lawsuit over pricing, filed a motion seeking a summary judgment in the matter in U.S. District Court for the Middle District of Florida here earlier this week, according to a
- Adolescents With Strabismus More Likely to Have Psychological Problemshttps://modernod.com/news/adolescents-with-strabismus-more-likely-to-have-psychological-problems/2479912/Adolescents with visible eye deviation due to strabismus may be prone to psychological problems, researchers in Turkey report. “The visible eye deviation caused by strabismus was a strong indicator of psychological distress in
- FDA Approves First Drug for Neurotrophic Keratitishttps://modernod.com/news/fda-approves-first-drug-for-neurotrophic-keratitis/2479917/The FDA approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea. “While the prevalence of neurotrophic keratitis is low, the impact of this serious condition on an individual patient can be devastating,” Wiley Chamber
- Lenstec Completes Enrollment of FDA Trial for SBL-3 IOLhttps://modernod.com/news/lenstec-completes-enrollment-of-fda-trial-for-sbl-3-iol/2479919/Lenstec announced that it has completed enrollment of the FDA trial for the SBL-3 IOL. The Lenstec SBL-3 IOL (segmented bifocal lens) is a non-concentric asymmetric multifocal refractive IOL that provides patients with superior near, intermediate, and distance vision. It also improves contrast se
- Staying Fit Might Cut Glaucoma Riskhttps://modernod.com/news/staying-fit-might-cut-glaucoma-risk/2479921/Meeting physical activity guidelines and being physically fit may reduce the risk of developing glaucoma by 40 percent to 50 percent, recent research suggests, according to a Reuters
- Penn’s Experimental Gene Therapy Saves Night Vision in Dogs, Paving the Way for Human Testshttps://modernod.com/news/penns-experimental-gene-therapy-saves-night-vision-in-dogs-paving-the-way-for-human-tests/2479925/In 1990, scientists discovered a genetic mutation that turns an important light-sensing protein in the retina into a toxin that steadily destroys the ability to see in low light. <